vendredi 14 février 2014

A Biological Marker Within Brain Tumors

By Robert Sutter


Brain tumors are, by nature, some of the most intricate substances that can be seen in the human body. There are so many different details that can be uncovered and each of them deserve the attention that they are given. Certain articles have been able to focus on his point, which probably goes without saying. However, one particular story has been able to talk about biological markers and I feel as though this is a subject that deserves far more attention than it has been given.

An article on Bioscience Technology went into detail about the matter. The report said that scientists at the Washington University School of Medicine in St. Louis identified a biological marker related to this type of cancer. What it may be able to do is predict the survival of those who are afflicted with these tumors. I believe that the study was worth doing, especially when considering the type of condition that has been put in place for a number of other procedures in the past.

It was later found out that those who have this marker present at higher levels are going to have more aggressive glioblastomas, the most common and aggressive growths in the brain. The article spoke about F11R, a marker that is created in the brain. Instead of being created by cancerous cells, though, it is formed by noncancerous cells, typically for the sake of protecting the healthier cells. What has been found out, though, is that it can offer support to the cancerous ones, helping them along as well.

Organizations such as Voices against Brain Cancer will be able to shed light on the situation of monocytes and their functionality in the brain. What has to be said is how they are able to adapt, being able to thrive regardless of the various biological changes that have been found in the brain. It's clear that remedies have to be found in order to keep this condition to a minimum. I believe that this is where brain tumors will be able to be brought down the most.

I believe that there are various triggers that can be had for brain tumors, considering just how detailed they are. For example, certain markers can come into play and I'd like to think that this particular story focused on F11R rather well. It goes to show that there is so much that can be said about these growths and I do not think that anyone can say differently. My only hope is that better therapies will be created for the sake of finding more solid treatment options.




About the Author:



Aucun commentaire:

Enregistrer un commentaire